- Home
- EGY vs SOPH Comparison
EGY vs SOPH Comparison
Compare EGY & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EGY | SOPH |
|---|---|---|
| Founded | 1985 | 2011 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 536.9M | 367.7M |
| IPO Year | 1996 | 2021 |
Fundamental Metrics
Financial Performance| Metric | EGY | SOPH |
|---|---|---|
| Price | $5.20 | $4.34 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $7.30 | $7.00 |
| AVG Volume (30 Days) | ★ 1.1M | 138.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 4.73% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.16 | N/A |
| Revenue | ★ $478,988,000.00 | N/A |
| Revenue This Year | N/A | $18.48 |
| Revenue Next Year | $14.93 | $16.25 |
| P/E Ratio | $32.84 | ★ N/A |
| Revenue Growth | ★ 5.26 | N/A |
| 52 Week Low | $3.00 | $2.58 |
| 52 Week High | $5.48 | $5.70 |
Technical Indicators
Market Signals| Indicator | EGY | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 59.38 | 34.34 |
| Support Level | $3.47 | $3.79 |
| Resistance Level | $5.38 | $4.85 |
| Average True Range (ATR) | 0.24 | 0.28 |
| MACD | -0.01 | -0.04 |
| Stochastic Oscillator | 64.01 | 26.96 |
Price Performance
Historical ComparisonAbout EGY VAALCO Energy Inc.
VAALCO Energy Inc is an independent energy company operating in the United States. It is principally engaged in the acquisition, exploration, development, and production of crude oil and natural gas. The company operates through geographical segments namely Gabon, Egypt, Canada, Equatorial Guinea, and Cote d'Ivoire. The company generates maximum revenue from the Gabon segment.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.